Along with the above-mentioned 2-HG generation by PHGDH, these results suggest that the inhibition of 2-HG production may be of therapeutic value in relevant cancers with an IDH wildtype (WT) and a high level of 2-HG. This evidence concerns the gene IDH1 and cancer.